drugset / Trial / NCT07796152
Suzetrigine vs. Standard Care Pain Relief Following Outpatient Knee Replacement Surgery
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this research is to see if a person having an outpatient total knee replacement will have a difference in their pain and the amount of pain medication (opioids) used after discharge if they are given suzetrigine (a non-opioid pain medicine, also known as Journavx®) in addition to the standard pain medicines usually prescribed. Participants will complete a daily pain and medication diary and survey for up to 14 days post-operatively and on day 30.
Timeline
- Start
- 2026-09
- Primary completion
- 2027-12
- Completion
- 2028-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxycodone | Other / unclassified | — | — |
| Subject | Suzetrigine | Small molecule | 50 mg | — |
| Subject | Tramadol | Other / unclassified | — | — |
| Subject | hydrocodone/acetaminophen | Unknown | — | — |
Indications
No indication recorded.